AbbVie Inc. Files 8-K: Senior Notes and Stock Details
Ticker: ABBV · Form: 8-K · Filed: Feb 19, 2025 · CIK: 1551152
| Field | Detail |
|---|---|
| Company | Abbvie Inc. (ABBV) |
| Form Type | 8-K |
| Filed Date | Feb 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: debt, filing, financials
Related Tickers: ABBV
TL;DR
ABBV filed an 8-K on Feb 18, 2025, detailing senior notes and common stock. Check for debt maturity and share info.
AI Summary
On February 18, 2025, AbbVie Inc. filed an 8-K report detailing other events and financial statements. The filing includes information about its common stock and various senior notes due in 2027, 2028, 2029, and 2031. The company's principal executive offices are located at 1 North Waukegan Road, North Chicago, IL 60064.
Why It Matters
This filing provides investors with updated information regarding AbbVie's outstanding debt instruments and common stock, which are crucial for assessing the company's financial structure and potential investment risks.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting financial details and does not indicate any unusual or negative events.
Key Numbers
- 2027 — Senior Notes Maturity Year (Indicates upcoming debt obligations)
- 2028 — Senior Notes Maturity Year (Indicates upcoming debt obligations)
- 2029 — Senior Notes Maturity Year (Indicates upcoming debt obligations)
- 2031 — Senior Notes Maturity Year (Indicates upcoming debt obligations)
Key Players & Entities
- AbbVie Inc. (company) — Filer of the 8-K report
- February 18, 2025 (date) — Earliest event date reported
- 1 North Waukegan Road, North Chicago, IL 60064 (location) — Principal executive offices
- 0.750 Percent due 2027 (dollar_amount) — Senior notes maturity
- 2.125 Percent due 2028 (dollar_amount) — Senior notes maturity
- 2.625 Percent due 2028 (dollar_amount) — Senior notes maturity
- 2.125 Percent due 2029 (dollar_amount) — Senior notes maturity
- 1.250 Percent due 2031 (dollar_amount) — Senior notes maturity
FAQ
What specific 'Other Events' are detailed in this 8-K filing?
The filing primarily details information related to AbbVie Inc.'s common stock and various senior notes with different maturity dates (2027, 2028, 2029, 2031), rather than specific operational events.
What is the par value of AbbVie Inc.'s common stock?
The par value of AbbVie Inc.'s common stock is $0.01.
On what date was this 8-K report filed?
This 8-K report was filed on February 19, 2025, with the earliest event reported being February 18, 2025.
What are the maturity dates for the senior notes mentioned in the filing?
The senior notes mentioned have maturity dates in 2027, 2028, 2029, and 2031.
Where are AbbVie Inc.'s principal executive offices located?
AbbVie Inc.'s principal executive offices are located at 1 North Waukegan Road, North Chicago, IL 60064.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 19, 2025 regarding AbbVie Inc. (ABBV).